Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
April 30, 2025
Women’s Health Weekly News – April 30th 2025
April 29, 2025
Obesity Weekly News – April 29th 2025
April 29, 2025
Endocrinology Weekly Update – 29th April 2025
April 28, 2025
Hematology Weekly News – April 28th 2025
April 28, 2025
Oncology Weekly News – April 28th 2025
April 27, 2025
Artificial Intelligence and Digital Health Weekly News – April 27th 2025
April 26, 2025
AUA 2025 Preview: Key Highlights in Urology to Watch
April 25, 2025
Trending at ASCO GU 2025 : Social Media Insights from X
April 25, 2025
AACR 2025 Preview: Key Cancer Research Highlights to Watch
April 25, 2025
Respiratory Weekly News – 25th April 2025
April 25, 2025
Public Health Weekly News – 25th April 2025
April 25, 2025